• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Jennifer C. Boal

Rx Hall of Shame Update: Former Insys employee pleads guilty in US opioid drug probe; case against ex CEO Michael Babich, others, in pre-trial mode.

Steve Walker    July 7, 2017 September 6, 2017    No Comments on Rx Hall of Shame Update: Former Insys employee pleads guilty in US opioid drug probe; case against ex CEO Michael Babich, others, in pre-trial mode.

The News: A former employee of Insys Therapeutics Inc. (Chandler AZ) pleaded guilty last week to having conspired to defraud insurers into paying for an expensive fentanyl-based drug that is… Read more »

Corporate, Government    Alec Burlakoff, Charles Cooper, Elizabeth Gurrieri, Fentanyl, Insys Therapeutics Inc., Jeff Sessions, Jefferies, Jennifer C. Boal, Joseph Rowan, Michael Gurry, Michael L. Babich, Nathaniel Yeager, Patrick Burns, RBC Capital Markets, Reuters, Richard Simon, Rx Hall of Shame, Subsys, Sunrise Lee, Taxpayers Against Fraud Education Fund, The New York Times

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Healthcare stocks roar back after slump, while biotech IPOs continue stampede into pipeline.
  • Smartphones are revolutionizing medicine as new apps proliferate. Then there’s the Facebook lesson for and against trusting that your data...
  • US citizen denied life-saving bone-marrow transplant from Iranian brother due to Trump travel ban. My very brief take.
  • Report says hardly any physicians read the medical journals for their particular field. Has era of “evidence-free medicine” finally arrived?
  • Tiny Scottish biotech TauRx lobs bomb into Alzheimer’s fracas with Phase 3 success.
  • CAR-T Therapy: Personalized medicine with the promise of a cure; payers will decide who gets it
  • Akebia shares soar on rich partnership with Otsuka; risky but rational gamble?
  • Although more expensive, study says teaching hospitals save more lives. My personal take.
  • Tiny Scottish biotech TauRx lobs bomb into Alzheimer’s fracas with Phase 3 success.
  • Breakthrough study linking menopause to increased risk of Alzheimer’s explains why far more women than men get the disease; what...
  • Alarming study concludes most new, pricey cancer drugs don’t work; why are we just hearing about this?
  • Rx Hall of Shame Update: Former Insys employee pleads guilty in US opioid drug probe; case against ex CEO Michael...
Copyright 2018
Ribosome by GalussoThemes.com
Powered by WordPress